Gene · 54210
Papers3,294
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,294
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions. | PLoS One | 2026 | 41855211 | PubTator, text mining | PubMed |
| Molecular mechanisms of tumor-associated macrophages in hepatocellular carcinoma development and therapy. | World J Gastroenterol | 2026 | 41809883 | PubTator, text mining | PubMed |
| New Insights into the Role of NF-κB in Hepatitis B Virus Infection. | Int J Biol Sci | 2026 | 41800244 | PubTator, text mining | PubMed |
| A human cerebral organoid model of West Nile virus encephalitis shows innate immunocompetency. | Nat Commun | 2026 | 41794851 | PubTator, text mining | PubMed |
| High-throughput fragment screening identifies a new small molecule scaffold that modulates TREM2 Signaling. | Bioorg Med Chem | 2026 | 41793968 | PubTator, text mining | PubMed |
| Editorial: Residual cardiovascular risk in diabetes: current state and future perspectives. | Front Clin Diabetes Healthc | 2026 | 41789124 | PubTator, text mining | PubMed |
| Decoding lung-kidney interactions in sepsis: an integrated view of molecular mechanisms, pathophysiology, and therapeutic interventions. | Front Immunol | 2026 | 41789112 | PubTator, text mining | PubMed |
| Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression. | Front Immunol | 2026 | 41789075 | PubTator, text mining | PubMed |
| Characterization of the TREM-1 signaling landscape in human neutrophils. | PLoS One | 2026 | 41785288 | PubTator, text mining | PubMed |
| Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assay. | Brain Commun | 2026 | 41783831 | PubTator, text mining | PubMed |
| Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects. | J Cell Commun Signal | 2026 | 41783325 | PubTator, text mining | PubMed |
| Identification of plasma inflammatory biomarkers for Alzheimer's disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype. | Front Immunol | 2026 | 41782881 | PubTator, text mining | PubMed |
| HIV gp120 induces TREM1 expression through TLR-PGE₂ signalling in human monocyte-derived microglia. | J Neuroinflammation | 2026 | 41782012 | PubTator, text mining | PubMed |
| TWEAK is increased in ulcerative colitis and contributes to fibroblast-mediated monocyte activation via heterologous non-canonical NF-kB/STAT3 signaling. | J Crohns Colitis | 2026 | 41765035 | PubTator, text mining | PubMed |
| Comparative cross-methodological analysis of the IDH-wildtype glioblastoma tumor microenvironment. | J Cancer Res Clin Oncol | 2026 | 41762316 | PubTator, text mining | PubMed |
| Sex Differences in Cancer Immunotherapy-Clinical Evidence and Mechanisms With a Focus on NSCLC. | Immunol Rev | 2026 | 41761458 | PubTator, text mining | PubMed |
| Integrated bioinformatics and network search identify biomarkers and comorbid mechanisms of atrial fibrillation and ischemic stroke. | Medicine (Baltimore) | 2026 | 41760035 | PubTator, text mining | PubMed |
| Cardiac macrophages at the crossroads of inflammation, memory, and repair. | Immunohorizons | 2026 | 41758614 | PubTator, text mining | PubMed |
| Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy. | Eur Heart J | 2026 | 41758068 | PubTator, text mining | PubMed |
| Host-pathogen interaction in community-acquired pneumonia: a focus on the immune response. | Front Cell Infect Microbiol | 2026 | 41756780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54210/papers?page=4